annual cash & cash equivalents:
$4.63B+$1.14B(+32.47%)Summary
- As of today (May 20, 2025), GSK annual cash & cash equivalents is $4.63 billion, with the most recent change of +$1.14 billion (+32.47%) on December 31, 2024.
- During the last 3 years, GSK annual cash & cash equivalents has fallen by -$864.49 million (-15.72%).
- GSK annual cash & cash equivalents is now -56.22% below its all-time high of $10.58 billion, reached on December 31, 2009.
Performance
GSK Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$5.78B+$1.14B(+24.63%)Summary
- As of today (May 20, 2025), GSK quarterly cash & cash equivalents is $5.78 billion, with the most recent change of +$1.14 billion (+24.63%) on March 31, 2025.
- Over the past year, GSK quarterly cash & cash equivalents has increased by +$2.25 billion (+63.96%).
- GSK quarterly cash & cash equivalents is now -62.10% below its all-time high of $15.24 billion, reached on March 31, 2015.
Performance
GSK quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GSK Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.5% | +64.0% |
| 3 y3 years | -15.7% | -59.9% |
| 5 y5 years | -21.6% | -2.1% |
GSK Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.7% | +32.5% | -59.9% | +65.1% |
| 5 y | 5-year | -44.2% | +32.5% | -59.9% | +65.1% |
| alltime | all time | -56.2% | >+9999.0% | -62.1% | >+9999.0% |
GSK Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $5.78B(+24.6%) |
| Dec 2024 | $4.63B(+32.5%) | $4.63B(+8.5%) |
| Sep 2024 | - | $4.27B(+14.0%) |
| Jun 2024 | - | $3.75B(+6.4%) |
| Mar 2024 | - | $3.52B(+0.7%) |
| Dec 2023 | $3.50B(-18.0%) | $3.50B(-9.8%) |
| Sep 2023 | - | $3.88B(-2.1%) |
| Jun 2023 | - | $3.96B(+10.7%) |
| Mar 2023 | - | $3.58B(-16.0%) |
| Dec 2022 | $4.26B(-22.5%) | $4.26B(+5.9%) |
| Sep 2022 | - | $4.03B(-48.6%) |
| Jun 2022 | - | $7.84B(-45.6%) |
| Mar 2022 | - | $14.41B(+162.0%) |
| Dec 2021 | $5.50B(-33.8%) | $5.50B(+18.6%) |
| Sep 2021 | - | $4.64B(-4.4%) |
| Jun 2021 | - | $4.85B(-25.9%) |
| Mar 2021 | - | $6.54B(-21.2%) |
| Dec 2020 | $8.30B(+40.5%) | $8.30B(+50.7%) |
| Sep 2020 | - | $5.51B(-45.2%) |
| Jun 2020 | - | $10.05B(+70.4%) |
| Mar 2020 | - | $5.90B(-0.2%) |
| Dec 2019 | $5.91B(+20.2%) | $5.91B(+11.7%) |
| Sep 2019 | - | $5.29B(+1.3%) |
| Jun 2019 | - | $5.22B(-3.0%) |
| Mar 2019 | - | $5.39B(+9.6%) |
| Dec 2018 | $4.92B(-5.1%) | $4.92B(-0.5%) |
| Sep 2018 | - | $4.94B(-6.6%) |
| Jun 2018 | - | $5.29B(-5.7%) |
| Mar 2018 | - | $5.61B(+8.3%) |
| Dec 2017 | $5.18B(-13.9%) | $5.18B(-18.7%) |
| Sep 2017 | - | $6.37B(+22.8%) |
| Jun 2017 | - | $5.19B(-7.8%) |
| Mar 2017 | - | $5.63B(-6.5%) |
| Dec 2016 | $6.02B(-30.3%) | $6.02B(+0.6%) |
| Sep 2016 | - | $5.98B(-3.2%) |
| Jun 2016 | - | $6.18B(-2.5%) |
| Mar 2016 | - | $6.34B(-26.6%) |
| Dec 2015 | $8.64B(+27.9%) | $8.64B(-3.5%) |
| Sep 2015 | - | $8.95B(-24.5%) |
| Jun 2015 | - | $11.87B(-22.1%) |
| Mar 2015 | - | $15.24B(+125.7%) |
| Dec 2014 | $6.75B(-26.0%) | $6.75B(+1.3%) |
| Sep 2014 | - | $6.67B(+23.7%) |
| Jun 2014 | - | $5.39B(-7.9%) |
| Mar 2014 | - | $5.85B(-35.9%) |
| Dec 2013 | $9.13B(+35.0%) | $9.13B(+73.6%) |
| Sep 2013 | - | $5.26B(+21.3%) |
| Jun 2013 | - | $4.33B(-25.6%) |
| Mar 2013 | - | $5.82B(-13.9%) |
| Dec 2012 | $6.76B(-23.2%) | $6.76B(+22.9%) |
| Sep 2012 | - | $5.50B(-52.0%) |
| Jun 2012 | - | $11.46B(+27.5%) |
| Mar 2012 | - | $8.99B(+2.1%) |
| Dec 2011 | $8.80B(-5.8%) | $8.80B(+4.3%) |
| Sep 2011 | - | $8.44B(-10.1%) |
| Jun 2011 | - | $9.40B(-10.0%) |
| Mar 2011 | - | $10.44B(+11.7%) |
| Dec 2010 | $9.35B | $9.35B(-5.0%) |
| Sep 2010 | - | $9.84B(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $9.82B(-7.1%) |
| Mar 2010 | - | $10.57B(-0.1%) |
| Dec 2009 | $10.58B(+28.5%) | $10.58B(+2.3%) |
| Sep 2009 | - | $10.35B(+17.6%) |
| Jun 2009 | - | $8.80B(-1.4%) |
| Mar 2009 | - | $8.92B(+8.4%) |
| Dec 2008 | $8.24B(+22.6%) | $8.24B(-10.2%) |
| Sep 2008 | - | $9.17B(-7.7%) |
| Jun 2008 | - | $9.94B(+133.4%) |
| Mar 2008 | - | $4.26B(-36.6%) |
| Dec 2007 | $6.72B(+71.1%) | $6.72B(+60.3%) |
| Sep 2007 | - | $4.19B(+10.2%) |
| Jun 2007 | - | $3.80B(-2.4%) |
| Mar 2007 | - | $3.90B(-0.7%) |
| Dec 2006 | $3.93B(-45.8%) | $3.93B(-10.5%) |
| Sep 2006 | - | $4.39B(-37.2%) |
| Jun 2006 | - | $6.99B(-15.1%) |
| Mar 2006 | - | $8.23B(+13.8%) |
| Dec 2005 | $7.24B(+52.9%) | $7.24B(-32.7%) |
| Sep 2005 | - | $10.75B(+11.8%) |
| Jun 2005 | - | $9.61B(+83.5%) |
| Mar 2005 | - | $5.24B(+10.7%) |
| Dec 2004 | $4.73B(+175.4%) | $4.73B(+16.4%) |
| Sep 2004 | - | $4.07B(-11.6%) |
| Jun 2004 | - | $4.60B(+63.6%) |
| Mar 2004 | - | $2.81B(+63.7%) |
| Dec 2003 | $1.72B(+1.3%) | $1.72B(-38.1%) |
| Sep 2003 | - | $2.78B(+4.5%) |
| Jun 2003 | - | $2.66B(+86.5%) |
| Mar 2003 | - | $1.42B(-16.0%) |
| Dec 2002 | $1.70B(+63.1%) | $1.70B(+29.1%) |
| Sep 2002 | - | $1.31B(-23.7%) |
| Jun 2002 | - | $1.72B(+29.4%) |
| Mar 2002 | - | $1.33B(+28.0%) |
| Dec 2001 | $1.04B(-45.7%) | $1.04B(-40.2%) |
| Sep 2001 | - | $1.74B(+32.2%) |
| Jun 2001 | - | $1.31B(-46.7%) |
| Mar 2001 | - | $2.47B(+29.0%) |
| Dec 2000 | $1.91B(+445.5%) | $1.91B(+170.2%) |
| Sep 2000 | - | $708.02M(-4.8%) |
| Jun 2000 | - | $743.56M(-18.0%) |
| Mar 2000 | - | $906.62M(+158.6%) |
| Dec 1999 | $350.65M(-11.7%) | $350.65M(-15.0%) |
| Jun 1999 | - | $412.65M(+4.0%) |
| Dec 1998 | $396.94M(+11.5%) | $396.94M(+11.3%) |
| Jun 1998 | - | $356.77M(+0.2%) |
| Dec 1997 | $356.06M(-19.7%) | $356.06M(-19.7%) |
| Dec 1996 | $443.57M(+22.7%) | $443.57M(+270.3%) |
| Dec 1995 | $361.43M(+201.7%) | - |
| Jun 1995 | - | $119.79M(+41.4%) |
| Jun 1995 | $119.79M(+41.4%) | - |
| Jun 1994 | $84.73M(-10.9%) | $84.73M(-10.9%) |
| Jun 1993 | $95.05M(+108.4%) | $95.05M(+108.4%) |
| Jun 1992 | $45.60M(-17.3%) | $45.60M(-17.3%) |
| Jun 1991 | $55.16M(-88.1%) | $55.16M(-88.1%) |
| Jun 1990 | $463.64M(-48.0%) | $463.64M(-48.0%) |
| Jun 1989 | $891.14M(+1203.7%) | $891.14M(+1203.7%) |
| Jun 1988 | $68.35M(+84.6%) | $68.35M(+84.6%) |
| Jun 1987 | $37.03M(-30.9%) | $37.03M(-30.9%) |
| Jun 1986 | $53.57M | $53.57M |
FAQ
- What is GSK annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for GSK?
- What is GSK annual cash & cash equivalents year-on-year change?
- What is GSK quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for GSK?
- What is GSK quarterly cash & cash equivalents year-on-year change?
What is GSK annual cash & cash equivalents?
The current annual cash & cash equivalents of GSK is $4.63B
What is the all time high annual cash & cash equivalents for GSK?
GSK all-time high annual cash & cash equivalents is $10.58B
What is GSK annual cash & cash equivalents year-on-year change?
Over the past year, GSK annual cash & cash equivalents has changed by +$1.14B (+32.47%)
What is GSK quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of GSK is $5.78B
What is the all time high quarterly cash & cash equivalents for GSK?
GSK all-time high quarterly cash & cash equivalents is $15.24B
What is GSK quarterly cash & cash equivalents year-on-year change?
Over the past year, GSK quarterly cash & cash equivalents has changed by +$2.25B (+63.96%)